0001104659-23-070395.txt : 20230612 0001104659-23-070395.hdr.sgml : 20230612 20230612164849 ACCESSION NUMBER: 0001104659-23-070395 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230608 FILED AS OF DATE: 20230612 DATE AS OF CHANGE: 20230612 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WAGENHEIM PHILIP CENTRAL INDEX KEY: 0001405684 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39580 FILM NUMBER: 231008785 MAIL ADDRESS: STREET 1: 712 FIFTH AVENUE STREET 2: 49TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Immunome Inc. CENTRAL INDEX KEY: 0001472012 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770694340 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 665 STOCKTON DRIVE STREET 2: SUITE 300 CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 610-321-3700 MAIL ADDRESS: STREET 1: 665 STOCKTON DRIVE STREET 2: SUITE 300 CITY: EXTON STATE: PA ZIP: 19341 4 1 tm2318426d2_4seq1.xml OWNERSHIP DOCUMENT X0407 4 2023-06-08 0 0001472012 Immunome Inc. IMNM 0001405684 WAGENHEIM PHILIP C/O IMMUNOME, INC. 665 STOCKTON DRIVE, SUITE 300 EXTON PA 19341 1 0 0 0 0 Stock Option (Right to Buy) 4.84 2023-06-08 4 A 0 6500 0 A 2033-06-08 Common Stock 6500 6500 D The shares subject to the options shall vest 25% every quarter after the grant date. /s/ Purnanand D. Sarma, Attorney-in-Fact 2023-06-12